From: PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma
Characteristics
HR
95% CI
P value
G stage (G3 vs. G2 or G2 vs. G1)
0.71
0.43–1.15
0.162
TNM stage (III vs. II or II vs. I)
1.53
0.85–2.76
0.153
PRAF2 (high vs. low)
2.05
1.10–3.85
0.025*